Susquehanna International Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-215,124
| Closed | -$4.06M | – | 5279 |
|
|
2019
Q3 | $4.06M | Buy |
215,124
+130,854
| +155% | +$2.47M | ﹤0.01% | 756 |
|
|
2019
Q2 | $992K | Buy |
+84,270
| New | +$992K | ﹤0.01% | 2065 |
|
|
2019
Q1 | – | Sell |
-24,728
| Closed | -$253K | – | 5196 |
|
|
2018
Q4 | $253K | Buy |
+24,728
| New | +$253K | ﹤0.01% | 2728 |
|
|
2018
Q3 | – | Sell |
-140,071
| Closed | -$2.21M | – | 5288 |
|
|
2018
Q2 | $2.21M | Buy |
140,071
+113,373
| +425% | +$1.79M | ﹤0.01% | 952 |
|
|
2018
Q1 | $339K | Sell |
26,698
-47,492
| -64% | -$603K | ﹤0.01% | 2449 |
|
|
2017
Q4 | $849K | Buy |
74,190
+59,634
| +410% | +$682K | ﹤0.01% | 1917 |
|
|
2017
Q3 | $178K | Buy |
+14,556
| New | +$178K | ﹤0.01% | 2788 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4774 |
|
|
2017
Q1 | – | Sell |
-12,124
| Closed | -$252K | – | 4893 |
|
|
2016
Q4 | $252K | Buy |
+12,124
| New | +$252K | ﹤0.01% | 3549 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4378 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4478 |
|
|
2016
Q1 | – | Sell |
-43,277
| Closed | -$1.43M | – | 4670 |
|
|
2015
Q4 | $1.43M | Sell |
43,277
-62,506
| -59% | -$2.06M | ﹤0.01% | 1911 |
|
|
2015
Q3 | $3.47M | Buy |
105,783
+59,396
| +128% | +$1.95M | ﹤0.01% | 1137 |
|
|
2015
Q2 | $2.46M | Buy |
46,387
+18,606
| +67% | +$986K | ﹤0.01% | 1629 |
|
|
2015
Q1 | $802K | Buy |
+27,781
| New | +$802K | ﹤0.01% | 2662 |
|
|
2014
Q3 | – | Sell |
-11,251
| Closed | -$226K | – | 4463 |
|
|
2014
Q2 | $226K | Buy |
+11,251
| New | +$226K | ﹤0.01% | 3775 |
|